177 related articles for article (PubMed ID: 38612833)
1. Treatment Monitoring of a Patient with Synchronous Metastatic Angiosarcoma and Breast Cancer Using ctDNA.
Vannas C; Escobar M; Österlund T; Andersson D; Mouhanna P; Soomägi A; Molin C; Wennergren D; Fagman H; Ståhlberg A
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612833
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Molecular Insights of Radiation-Induced Breast Sarcomas: Is There Hope on the Horizon for Effective Treatment of This Aggressive Disease?
Kokkali S; Moreno JD; Klijanienko J; Theocharis S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456944
[TBL] [Abstract][Full Text] [Related]
3. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
[TBL] [Abstract][Full Text] [Related]
4. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study.
Yin M; Wang W; Drabick JJ; Harold HA
BMC Cancer; 2017 Apr; 17(1):295. PubMed ID: 28449661
[TBL] [Abstract][Full Text] [Related]
6. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study.
Veiga LHS; Vo JB; Curtis RE; Mille MM; Lee C; Ramin C; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Lancet Oncol; 2022 Nov; 23(11):1451-1464. PubMed ID: 36240805
[TBL] [Abstract][Full Text] [Related]
7. Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas.
Braig D; Runkel A; Eisenhardt AE; Schmid A; Zeller J; Pauli T; Lausch U; Wehrle J; Bronsert P; Jung M; Kiefer J; Boerries M; Eisenhardt SU
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142126
[TBL] [Abstract][Full Text] [Related]
8. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers.
Marchal C; Weber B; de Lafontan B; Resbeut M; Mignotte H; du Chatelard PP; Cutuli B; Reme-Saumon M; Broussier-Leroux A; Chaplain G; Lesaunier F; Dilhuydy JM; Lagrange JL
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):113-9. PubMed ID: 10219803
[TBL] [Abstract][Full Text] [Related]
9. Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer.
Kodahl AR; Ehmsen S; Pallisgaard N; Jylling AMB; Jensen JD; Laenkholm AV; Knoop AS; Ditzel HJ
Mol Oncol; 2018 Jun; 12(6):925-935. PubMed ID: 29689598
[TBL] [Abstract][Full Text] [Related]
10. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.
Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG
Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182
[TBL] [Abstract][Full Text] [Related]
11. Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.
Namløs HM; Zaikova O; Bjerkehagen B; Vodák D; Hovig E; Myklebost O; Boye K; Meza-Zepeda LA
BMC Cancer; 2017 Jan; 17(1):29. PubMed ID: 28061772
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients.
Darrigues L; Pierga JY; Bernard-Tessier A; Bièche I; Silveira AB; Michel M; Loirat D; Cottu P; Cabel L; Dubot C; Geiss R; Ricci F; Vincent-Salomon A; Proudhon C; Bidard FC
Breast Cancer Res; 2021 Mar; 23(1):31. PubMed ID: 33676547
[TBL] [Abstract][Full Text] [Related]
13. Combined Analysis of Disseminated Tumor Cells (DTCs) and Circulating Tumor DNA (ctDNA) in a Patient Suffering from Triple Negative Breast Cancer Revealed Elevated Risk.
Nel I; Herzog H; Aktas B
Front Biosci (Landmark Ed); 2022 Jun; 27(7):208. PubMed ID: 35866394
[TBL] [Abstract][Full Text] [Related]
14. Mutant
Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
[TBL] [Abstract][Full Text] [Related]
15. Current Management of Angiosarcoma: Recent Advances and Lessons From the Past.
Florou V; Wilky BA
Curr Treat Options Oncol; 2021 Jun; 22(7):61. PubMed ID: 34097172
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic study of angiosarcoma of the breast.
Gil-Benso R; López-Ginés C; Soriano P; Almenar S; Vazquez C; Llombart-Bosch A
Genes Chromosomes Cancer; 1994 Jul; 10(3):210-2. PubMed ID: 7522046
[TBL] [Abstract][Full Text] [Related]
17. Angiosarcoma: A rare malignancy with protean clinical presentations.
Huntington JT; Jones C; Liebner DA; Chen JL; Pollock RE
J Surg Oncol; 2015 Jun; 111(8):941-50. PubMed ID: 26031299
[TBL] [Abstract][Full Text] [Related]
18. [Rare tumors: Angiosarcoma].
El-Ghazzi N; Bay JO
Bull Cancer; 2023 May; 110(5):581-588. PubMed ID: 36973135
[TBL] [Abstract][Full Text] [Related]
19. Breast Angiosarcoma Surveillance Study: UK national audit of management and outcomes of angiosarcoma of the breast and chest wall.
Banks J; George J; Potter S; Gardiner MD; Ives C; Shaaban AM; Singh J; Sherriff J; Hallissey MT; Horgan K; Harnett A; Desai A; Ferguson DJ; Tillett R; Izadi D; Sadideen H; Jain A; Gerrand C; Holcombe C; Hayes A; Teoh V; Wyld L;
Br J Surg; 2021 Apr; 108(4):388-394. PubMed ID: 33749771
[TBL] [Abstract][Full Text] [Related]
20. Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.
Blumendeller C; Boehme J; Frick M; Schulze M; Rinckleb A; Kyzirakos C; Kayser S; Kopp M; Kelkenberg S; Pieper N; Bartsch O; Hadaschick D; Battke F; Stenzl A; Biskup S
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
